← FDA Drug Approvals (Drugs@FDA)
ELIGLUSTAT TARTRATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AIZANT · Approved 2021-09-08
Drug application
- FDA Application #
ANDA212463- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ELIGLUSTAT TARTRATE
- Generic name
- Eliglustat Tartrate
- Active ingredients
- ELIGLUSTAT TARTRATE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- AIZANT
- First approval
- 2021-09-08
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown